Search research articles
Contact Us
Filters
Showing results (211-220 of 527) with videos related to
Page
of 53
Sort By:
Antiviral Research
|
November 26, 2009
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Hepatology International
|
November 11, 2010
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients
Chung-Feng Huang, Ming-Yen Hsieh, Jeng-Fu Yang, et al.
Medicine
|
July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
Chung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
Medicine
|
March 18, 2008
Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study
Jen-Eing Jeng, Jung-Fa Tsai, Lea-Yea Chuang, et al.
The Journal of Infectious Diseases
|
December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology International
|
July 24, 2015
The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
Chung-Feng Huang, Jee-Fu Huang, Wu-Cheng Chen, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
Ming-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers
Chia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
The Kaohsiung Journal of Medical Sciences
|
November 5, 2020
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment
Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, et al.
Page
of 53
Search research articles
Search
Showing results (211-220 of 527) with videos related to
Sort By:
Page
of 53
Antiviral Research
|
November 26, 2009
Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients
Chia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 7, 2019
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee-Fu Huang, Pei-Chien Tsai, Ming-Lun Yeh, et al.
Hepatology International
|
November 11, 2010
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients
Chung-Feng Huang, Ming-Yen Hsieh, Jeng-Fu Yang, et al.
Medicine
|
July 12, 2016
Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
Chung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, et al.
Medicine
|
March 18, 2008
Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study
Jen-Eing Jeng, Jung-Fa Tsai, Lea-Yea Chuang, et al.
The Journal of Infectious Diseases
|
December 3, 2005
Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Hepatology International
|
July 24, 2015
The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
Chung-Feng Huang, Jee-Fu Huang, Wu-Cheng Chen, et al.
Hepatology (Baltimore, Md.)
|
October 24, 2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
Ming-Lung Yu, Shi-Ming Lin, Chuan-Mo Lee, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 18, 2003
Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers
Chia Yen Dai, Ming Lung Yu, Zu Yau Lin, et al.
The Kaohsiung Journal of Medical Sciences
|
November 5, 2020
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment
Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, et al.
Page
of 53